Eterna Therapeutics Changes Name to Ernexa Therapeutics to Reflect New Strategic Focus on Ovarian Cancer and Autoimmune Disease
Ernexa Therapeutics embarks on new strategic direction, shifting the company’s focus from delivering a cell therapy platform to prioritizing ...
BioPharma Dive7h
Character Biosciences raises $93M with an eye on vision loss drugs
The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...